Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Frontiers in Medicine|June 24, 2026
Sigmoid colonic tuberculosis presenting as a colovesical fistula mimicking colorectal malignancy: a case reportLingfeng Zhong, Kun Xia, Yanyun FanHeliyon|March 6, 2024
Multicomponent comprehensive confirms that erythroferrone is a molecular biomarker of pan-cancerYing Cai, Yaling Gao, Yinyin Lv, et al.Frontiers in Cell and Developmental Biology|November 25, 2021
GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome ActivationShanshan Dai, Bozhi Ye, Lingfeng Zhong, et al.BMC Cardiovascular Disorders|December 21, 2022
Elevated circulating levels of gasdermin D are related to acute myocardial infarction and pyrogptosisYawen Weng, Bozhi Ye, Jiahui Lin, et al.Experimental Cell Research|October 24, 2025
A tRNA-derived fragment tiRNA-Met-CAT-002 induced by myocardial ischemia/reperfusion injury inhibits cardiomyocyte autophagy by regulating Bnip3Lang Deng, Yawen Weng, Jiahui Lin, et al.Cardiovascular Drugs and Therapy|June 24, 2022
Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling PathwaysYanghao Chen, Wante Lin, Lingfeng Zhong, et al.Clinical and Translational Medicine|October 3, 2025
Cardiomyocyte USP20 alleviates septic cardiomyopathy by deubiquitinating and inhibiting NLRP3 activityShanshan Dai, Yucong Zhang, Ziyi Huang, et al.Genes|November 24, 2022
Oridonin Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting GSDMD-Mediated PyroptosisJiahui Lin, Xianhui Lai, Xiaoxi Fan, et al.Clinical and Translational Medicine|February 22, 2025
Ubiquitin-specific protease 25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytesBozhi Ye, Diyun Xu, Lingfeng Zhong, et al.Basic Research in Cardiology|October 2, 2023
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formationLingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.Pageof 2